NCT04224337 2025-12-31
Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma
Seoul National University Hospital
Phase 2 Completed
Clinical Trials
10 trialsNCT00003860 2021-02-21
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
UNICANCER
Phase 2 Completed
NCT03034850 2017-01-27
Thrombin Generation and Platelet Activation in CRS/HIPEC
Ziekenhuis Oost-Limburg
Completed
NCT00003657 2017-01-20
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01784107 2016-02-10
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
Gachon University Gil Medical Center
Phase 1/2 Unknown
NCT00004186 2013-04-12
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
University of Alabama at Birmingham
Phase 1/2 Completed
NCT00622349 2013-01-30
Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer
European Lung Cancer Working Party
Phase 3 Completed
NCT01752517 2012-12-19
Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
Peking Union Medical College Hospital
Unknown
NCT01749072 2012-12-13
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
Peking Union Medical College Hospital
Phase 2 Unknown
NCT00148395 2008-04-22
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.
Aktion Bronchialkarzinom e.V.
Phase 3 Completed